Search Results - "Berendzen, Ashley"
-
1
Interactive Effects of Perinatal BPA or DES and Adult Testosterone and Estradiol Exposure on Adult Urethral Obstruction and Bladder, Kidney, and Prostate Pathology in Male Mice
Published in International journal of molecular sciences (30-05-2020)“…Obstructive voiding disorder (OVD) occurs during aging in men and is often, but not always, associated with increased prostate size, due to benign prostatic…”
Get full text
Journal Article -
2
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
Published in Molecular therapy. Nucleic acids (12-12-2023)“…A significant fraction of non-small cell lung cancer (NSCLC) cases are due to oncogenic mutations in the tyrosine kinase domain of the epidermal growth factor…”
Get full text
Journal Article -
3
Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis
Published in EJNMMI research (13-07-2023)“…Background CXCR3 is a chemokine receptor and is expressed in innate and adaptive immune cells. It promotes the recruitment of T-lymphocytes and other immune…”
Get full text
Journal Article -
4
Evaluation of 72Se/72As generator and production of 72Se for supplying 72As as a potential PET imaging radionuclide
Published in Applied radiation and isotopes (01-01-2019)“…Positron-emitting 72As is the PET imaging counterpart for beta-emitting 77As. Its parent, no carrier added (n.c.a.) 72Se, was produced for a 72Se/72As…”
Get full text
Journal Article -
5
Abstract 4412: Assessing protease inhibition enhanced delivery of prostate tumor targeted peptide receptor based radiotherapy
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Purpose: Peptide receptor targeted therapy for treatment of castration resistant prostate cancer (CRPC) has been explored by several groups including our own…”
Get full text
Journal Article -
6
Synthesis and evaluation of Re/99mTc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent
Published in Bioorganic & medicinal chemistry (01-02-2019)“…[Display omitted] The somatostatin receptor subtype 2 (SSTR2) is often highly expressed on neuroendocrine tumors (NETs), making it a popular in vivo target for…”
Get full text
Journal Article -
7
Targeting the BB2 receptor in prostate cancer using a Pb-203 labeled peptide
Published in The Journal of nuclear medicine (1978) (01-05-2017)“…Objectives: The objective of this study is to prepare and assess the efficacy of in vivo tumor targeting of 203Pb-RM2, a BB2r antagonist, for targeting BB2r…”
Get full text
Journal Article -
8
Abstract 4927: 68Ga/177Lu-Peptide antagonist targeting of breast cancer: A xenograft evaluation
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Introduction: Recent progress in developing BB2r (bombesin receptor subtype 2) antagonist vectors with long term cellular retention has captured significant…”
Get full text
Journal Article -
9
Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors
Published in Nuclear medicine and biology (01-04-2017)“…A somatostatin receptor (SSTR)-targeting antagonist peptide (sst2-ANT) was radiolabeled with 99mTc tricarbonyl via a tridentate [N,S,N]-type ligand (L) to…”
Get full text
Journal Article -
10
Synthesis and evaluation of a99m Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors
Published in Nuclear medicine and biology (2016)“…Abstract Introduction A somatostatin receptor (SSTR)-targeting antagonist peptide (sst2 -ANT) was radiolabeled with99m Tc tricarbonyl via a tridentate…”
Get full text
Journal Article -
11
Synthesis and evaluation of Re/ 99m Tc(I) complexes bearing a somatostatin receptor-targeting antagonist and labeled via a novel [N,S,O] clickable bifunctional chelating agent
Published in Bioorganic & medicinal chemistry (01-02-2019)“…The somatostatin receptor subtype 2 (SSTR2) is often highly expressed on neuroendocrine tumors (NETs), making it a popular in vivo target for diagnostic and…”
Get full text
Journal Article -
12
Synthesis and evaluation of a 99m Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors
Published in Nuclear medicine and biology (01-04-2017)“…A somatostatin receptor (SSTR)-targeting antagonist peptide (sst -ANT) was radiolabeled with Tc tricarbonyl via a tridentate [N,S,N]-type ligand (L) to develop…”
Get full text
Journal Article -
13
Evaluation of 72 Se/ 72 As generator and production of 72 Se for supplying 72 As as a potential PET imaging radionuclide
Published in Applied radiation and isotopes (01-01-2019)“…Positron-emitting As is the PET imaging counterpart for beta-emitting As. Its parent, no carrier added (n.c.a.) Se, was produced for a Se/ As generator by…”
Get full text
Journal Article